Purespring Advances Kidney-Targeted Gene Therapy PS-003 Toward Clinic
Purespring Therapeutics says it presented new preclinical and epidemiological data on PS-003 for X-linked Alport syndrome at ASN Kidney Week 2026.
Purespring Therapeutics says it presented new preclinical and epidemiological data on PS-003 for X-linked Alport syndrome at ASN Kidney Week 2026.